Jacqueline Kosecoff, PhD

Dr. Kosecoff is CEO, Prescriptions Solutions (RxS), UnitedHealth Group. She is responsible for United’s PBM, Specialty Pharmacy, and Consumer Health Products. UnitedHealth Group is a diversified health and well-being company, serving approximately 70 million Americans.

Dr. Kosecoff joined UnitedHealth Group as part of its acquisition of PacifiCare Health Systems in 2005. At PacifiCare, Dr. Kosecoff served as Executive Vice President with responsibility for its specialty businesses, including its PBM, the Medicare Part D Drug Program, PacifiCare Behavioral Health (PBH), PacifiCare Dental & Vision (PDV), and Women’s Health Solutions.

Prior to joining UnitedHealth Group-PacifiCare, Dr. Kosecoff was founder, President and Chief Operating Officer of Protocare (now Constella Health Strategies and Radiant Research), a firm whose lines of business included the clinical development of drugs, devices, biopharmaceutical and nutritional products and health services consulting. Dr. Kosecoff was co-founder and Co-CEO of Value Health Sciences (VHS), a wholly owned subsidiary of Value Health, Inc. (NYSE: VHI). VHS was the first company to combine medical sciences and information technology to reengineer the utilization review and approval process, saving payors millions while improving the quality of care.

Dr. Kosecoff served as Professor of Medicine and Public Health at the University of California, Los Angeles, where she still holds a Research Professorship.

In addition to her accomplishments as an entrepreneur, Dr. Kosecoff is a recognized expert in the areas of clinical and health services research, quality of care and technology assessment, disease management, and organization of the health care delivery system. She has published extensively in such journals as the New England Journal of Medicine, Journal of the American Medical Association, and the Annals of Internal Medicine. She has served as a consultant to the World Health Organization’s Global Quality Assessment Programs, on the Institute of Medicine’s Board of Health Care Services, the RAND Graduate School’s Board of Governors, and the Board of Directors for ALARIS (NYSE: AMI) now part of Cardinal Health. Currently, Dr. Kosecoff sits on the board of directors for City of Hope, Pharmaceutical Care Management Association (PCMA), Sealed Air Corporation (NYSE: SEE), STERIS Corporation (NYSE: STE), and the Alliance for Aging Research and serves on the Catalyst Western Region Advisory Board.

Dr. Kosecoff holds a BA from the University of California, Los Angeles (UCLA), an MS in Applied Mathematics from Brown University, and a doctorate in Research Methods from UCLA.